1. Home
  2. TEVA vs EC Comparison

TEVA vs EC Comparison

Compare TEVA & EC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • EC
  • Stock Information
  • Founded
  • TEVA 1901
  • EC 1948
  • Country
  • TEVA Israel
  • EC Colombia
  • Employees
  • TEVA N/A
  • EC N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • EC Oil & Gas Production
  • Sector
  • TEVA Health Care
  • EC Energy
  • Exchange
  • TEVA Nasdaq
  • EC Nasdaq
  • Market Cap
  • TEVA 20.1B
  • EC 18.4B
  • IPO Year
  • TEVA N/A
  • EC 2007
  • Fundamental
  • Price
  • TEVA $16.65
  • EC $8.90
  • Analyst Decision
  • TEVA Strong Buy
  • EC Hold
  • Analyst Count
  • TEVA 8
  • EC 2
  • Target Price
  • TEVA $24.50
  • EC $9.50
  • AVG Volume (30 Days)
  • TEVA 10.6M
  • EC 2.6M
  • Earning Date
  • TEVA 07-30-2025
  • EC 08-12-2025
  • Dividend Yield
  • TEVA N/A
  • EC 11.15%
  • EPS Growth
  • TEVA N/A
  • EC N/A
  • EPS
  • TEVA N/A
  • EC 0.08
  • Revenue
  • TEVA $16,616,000,000.00
  • EC $31,805,322,103.00
  • Revenue This Year
  • TEVA $5.69
  • EC N/A
  • Revenue Next Year
  • TEVA N/A
  • EC N/A
  • P/E Ratio
  • TEVA N/A
  • EC $109.11
  • Revenue Growth
  • TEVA 3.82
  • EC N/A
  • 52 Week Low
  • TEVA $12.47
  • EC $7.21
  • 52 Week High
  • TEVA $22.80
  • EC $11.32
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 45.87
  • EC 44.86
  • Support Level
  • TEVA $16.42
  • EC $8.80
  • Resistance Level
  • TEVA $16.95
  • EC $9.95
  • Average True Range (ATR)
  • TEVA 0.46
  • EC 0.26
  • MACD
  • TEVA -0.11
  • EC -0.08
  • Stochastic Oscillator
  • TEVA 16.79
  • EC 8.26

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About EC Ecopetrol S.A.

Ecopetrol SA is engaged in commercial and industrial activities related to the exploration, exploitation, refining, transportation, storage, distribution, and marketing of hydrocarbons, their derivatives, and products, as well as the electric power transmission services, design, development, construction, operation, and maintenance of road and energy infrastructure projects and the provision of information technology and telecommunications services. The operations of the company are performed through four business segments: Exploration and Production, Transport and Logistics, Refining and Petrochemical, and Electric Power Transmission and Toll Roads Concessions. The majority of the company's revenue is generated from the Refining and Petrochemical segment.

Share on Social Networks: